Since Rho GTPases were reported to control cytoskeleton organization and cellular activities, such as the JNK (c-Jun N-terminal kinase) and p38 MAPK (mitogen-activated protein kinase) cascades [88], it is conceivable that Vav1 also controls these pathways in cancer. This evidence concerns the gene VAV1 and cancer.